[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Publication Ethics::
Indexed & full text in


Journal's Impact Factor


             "If you have any questions or concerns, please contact us by email

Journal`s Impact Factor 2023:0.985
Journal's Impact Factor ISC 2020: 0.476


Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Abstract in

 پایگاه استنادی علوم جهان اسلام (ISC)

پایگاه اطلاعات جهاد دانشگاهی (SID) 

بانک نشریات کشور (مگیران)




Journal DOI

Journal DOI


:: Volume 22, Issue 5 (2023) ::
IJFS 2023, 22 Back to browse issues page
Research Article: Enhancing Nile tilapia health status and immunity against Aeromonas hydrophila with a combination of probiotics and immunostimulants (Vimolert®)
O.A. Abd Allah , Aly S.M. , M.E. Abo El-Atta , S.A. Metwaly , E.H. Mohamed , M. Fathi *
Fish Diseases Laboratory, Aquaculture Division, National Institute of Oceanography and Fisheries (NIOF), Cairo, Egypt , aquavet@hotmail.com
Abstract:   (387 Views)
This study explores the potential of the probiotics and immunostimulants combination (Vimolert®) to enhance the blood biochemistry profile, histopathology, and immune response of Nile Tilapia against Aeromonas hydrophila infection. A total of 150 Nile tilapia were used and divided into five groups, including a negative control group, a positive control group, and three groups fed with Vimolert®-supplemented diets at different doses for four weeks. After this period, groups 2 to 5 were infected with A. hydrophila. The biochemistry parameters including alanine aminotransferase, Aspartate aminotransferase, alkaline phosphatase, urea, and creatinine significantly increased in the positive control group compared to the treated groups. The total protein and albumin levels were significantly lower in the positive control group than in the treated groups, while the globulin level was higher in the treated groups than in the positive control group. Regarding the immune response, which includes nitroblue tetrazolium and lysozyme activity, it was observed that the groups receiving Vimolert® experienced significant increases in the fourth and sixth weeks compared to the positive control group. The histopathological examination unveiled that the positive control group exhibited pronounced pathological alterations, including degeneration and necrosis in the liver tissue, necrosis, and a reduction in hematopoietic cells in the kidney tissue, as well as edema, degeneration, and necrosis in the muscle tissue. Furthermore, there were infiltrations of mononuclear cells and melanomacrophages between the necrotic muscle fibers. In contrast, the treated group displayed milder to moderately altered tissue conditions. Group 4 had the maximum protection after infection compared to the other treated groups. In conclusion, this study underscores the potential of Vimolert® (a mixture of probiotics and immunostimulants) in improving the immune response and resistance of Nile tilapia against A. hydrophila infection. This finding holds significant promise for enhancing the health status and survival of Nile Tilapia in the aquaculture industry, thereby contributing to the sustainability and productivity of this industry.
Keywords: Nile tilapia, Preventive measures, Aeromonas hydrophila infection, Biochemistry profile, Histopathological changes, Immune response
Full-Text [PDF 657 kb]   (195 Downloads)    
Type of Study: Orginal research papers | Subject: fish disease
Received: 2023/06/25 | Accepted: 2023/09/17 | Published: 2023/12/31
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abd Allah O, S.M. A, Abo El-Atta M, Metwaly S, Mohamed E, Fathi M. Research Article: Enhancing Nile tilapia health status and immunity against Aeromonas hydrophila with a combination of probiotics and immunostimulants (Vimolert®). IJFS 2023; 22 (5) :940-961
URL: http://jifro.ir/article-1-5392-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 22, Issue 5 (2023) Back to browse issues page
Iranian Journal of Fisheries Sciences Iranian Journal of Fisheries Sciences
Persian site map - English site map - Created in 0.06 seconds with 45 queries by YEKTAWEB 4642